Cargando…
Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population
BACKGROUND: Acquired myasthenia gravis (MG) is a rare antibody-mediated autoimmune disease caused by impaired neuromuscular transmission, leading to abnormal muscle fatigability. The aetiology is complex, including genetic risk factors of the human leukocyte antigen (HLA) complex and unknown environ...
Autores principales: | Maniaol, Angelina H., Elsais, Ahmed, Lorentzen, Åslaug R., Owe, Jone F., Viken, Marte K., Sæther, Hanne, Flåm, Siri T., Bråthen, Geir, Kampman, Margitta T., Midgard, Rune, Christensen, Marte, Rognerud, Anna, Kerty, Emilia, Gilhus, Nils Erik, Tallaksen, Chantal M. E., Lie, Benedicte A., Harbo, Hanne F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348874/ https://www.ncbi.nlm.nih.gov/pubmed/22590574 http://dx.doi.org/10.1371/journal.pone.0036603 |
Ejemplares similares
-
Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset
por: Popperud, T. H., et al.
Publicado: (2017) -
Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014) -
Myasthenia Gravis: A Review of Available Treatment Approaches
por: Gilhus, Nils Erik, et al.
Publicado: (2011) -
Fatigue in myasthenia gravis: is it more than muscular weakness?
por: Elsais, Ahmed, et al.
Publicado: (2013) -
Imaging in Lyme neuroborreliosis
por: Lindland, Elisabeth S., et al.
Publicado: (2018)